AAC Holdings, Inc. (NYSE: AAC), operator of American Addiction Centers, announced its first acquisition of 2017. The company is ramping up again after a hot streak in 2015, when it acquired seven companies for a combined $143 million. Since then, the once-serial acquirer has been quiet on the M&A front as it integrated all its […]
Health Care M&A Weekly Deals, The Week Ending September 15, 2017
Revenue cycle management companies remain a strong investment opportunity for financial buyers. As of Mid-September 2017, 52% of RCM targets were acquired by private equity firms or other PE-backed eHeath companies. One Georgia-based RCM firm continues to thrive following an investment from Bain Capital.
Last week, Teva Pharmaceutical Industries Ltd. (NYSE: TVA) divested more than $1.1 billion of assets in response to increasing financial pressure. Just this August, Credit Suisse lowered its rating on Teva’s stock from neutral to underperform, citing industry-wide pricing pressure for generic drugs. Credit Suisse’s announcement follows Teva’s acquisition of Allergan’s (NYSE: AGN) generic division, […]
Centene Corporation (NYSE: CNC), the self-declared leader in government-sponsored healthcare in the U.S., has taken over another state. As larger rivals like Anthem (NYSE: ANTM) and UnitedHealth Group (NYSE: UNH) quit the individual health insurance exchanges around the country, Centene has marched in. In its first major deal since July 2015, Centene is now tops […]
Mergers and acquisitions in the Behavioral Health Care sector have been on a tear in recent years, relatively speaking. The caveat is that many deals are done locally, between private or not-for-profit organizations, and most are not publicly announced. Private equity firms have been piling into this space, and they aren’t known for a lot […]
Since July, we’ve seen several headlines in the trades regarding deal making activity in various healthcare sectors. We’ve also attended several conferences and forums focused on healthcare deal making. What we hear at those conferences is usually closer to the truth than what we’ve read. It may be all about the methodology, but here’s our […]
The dog days of summer weren’t really all that hot, here in the Northeast. Neither was August’s deal volume. Although it’s preliminary data, the 102 deals posted in August equalled the total in July. Compared with the same month in 2016, that represents a 22% slide in deal volume.
The Deal of the Week (ended Sept. 8, 2017) is also the largest announced in the holiday-shortened work week. Teleflex Incorporated (NYSE: TFX) announced its first acquisition this year, paying $725 million upfront for privately held NeoTract, Inc. It marks a new focus for the medical device maker, whose previous buyouts concentrated in cardiovascular and microlaparoscopy […]
Health Care M&A Weekly Deals, The Week Ending September 8, 2017
About Us | Advertise With Us | Contact Us | Order | Privacy | Disclaimer | Recent Press
Irving Levin Associates, Inc. | 268 1/2 Main Avenue, Norwalk, CT 06851
Phone: 203-846-6800 | Fax: 203-846-8300 | info@levinassociates.com
© 2017 Irving Levin Associates, Inc. All Rights Reserved